Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Post by Duster340on Jul 07, 2022 4:30pm

filled at the close

as the stock drops to 60 cents. looks like about a month before the next blackout period, will management step up and support the (s.p.) or are they with the shorts and hopeing to get in cheaper ...more  
Comment by Doccoleon Jul 07, 2022 11:57am

RE:20000 shares at .62

0 shares traded in USA for almost 2 days now. probably because I'm done buying.   No bueno here
Post by Duster340on Jul 07, 2022 10:48am

Just got a partial fill

@61  62 is still on the ask
Post by Stutterson Jul 07, 2022 10:25am

20000 shares at .62

and no insider buying.
Post by Duster340on Jul 06, 2022 8:03pm

RE: No insider buying

correction*  i meant to say Q1 august /29/ 2022 Antibe Therapeutics Earnings Date & Reports FollowPortfolio    ...more  
Comment by davgroon Jul 06, 2022 6:09pm

RE:Q1 2023 Earnings Expected Report Date - August 20th, 2022

Link to report is below: https://drive.google.com/file/d/1jil8tHcOOedFkmt0iPLVGUJm-jBpyKQk/view?usp=sharing
Post by davgroon Jul 06, 2022 6:01pm

Q1 2023 Earnings Expected Report Date - August 20th, 2022

Today's Thomson Reuters StockReports+ for ATE has listed the next expected earnings report date (Q1 2023) as August 20th, 2022.
Post by Duster340on Jul 06, 2022 1:23pm

No Insider Buying

aproximately another  week before blackout ahead of Q1 financials. i do not expect anything new. therefore there will be no insider buying. i think management thinks they will be able to load up ...more  
Post by MrMugsyon Jul 05, 2022 11:58pm

AGM ...

Annual General Meeting seems to be set for September 9, 2022. See Sedar.
Comment by MrMugsyon Jul 05, 2022 11:28pm

RE:Stutters

You got your hands full with that sap Forestview - best to put his tush on ignore. You'd likely have a better conversation wtih my grandmother who had Alzheimer's ... before she went 6 feet ...more  
Comment by Stutterson Jul 05, 2022 6:51pm

RE:Stutters

Forestview, I have some Magic Beans for Sale. PM me if interested.
Post by Forestviewon Jul 05, 2022 5:42pm

Stutters

So, you make a comment that Paradigm doesn't own Antibe yet gives it a Buy rating.  But, if they did own it, which they would have to disclose, you'd accuse it of....let me guess, pumping ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities